explore -WSS

explore

author：knowledge 2025-08-03 10:41:55 - browse：212

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical records are filled with copy
Next article： Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

WSS

Virtual Event: March of the Biosimilars

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

App could help diagnose ear infections more accurately — and at home

Criminal prosecution for violating HIPAA: an emerging threat

UnitedHealth increases loan offers after Change Healthcare outage

Data integrity in scientific journals requires "effort" by publishers, institutions

knowledge

explore

entertainment

Jerome Adams on the need for new antivirals for Covid

Neuroscience’s long legacy of racism

ChatGPT in medicine: STAT answers readers' burning questions

AstraZeneca to buy developer of next

Peter Hotez and the public health issue of online harassment

Helping hospitals and community health centers plan for resilience

Medicare proposal to cover medical devices draws a mixed reaction

Readers respond to H5N1 and livestock movements, and more

Moonlake's readout produced a cash windfall. Risks remain

Stop the failed accountable care organization experiment

focus

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Asbestos, a deadly carcinogen, banned by EPA

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Case highlights the risks of experimental stem cell therapy

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Physicians and social media: If you see something, say something?

focus

focus

entertainment

focus